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BACKGROUND: Migraine is a chronic episodic disorder that is still under-diagnosed and undertreated. 
A rapid diagnostic method is desirable so that treatment can be initiated early. We compared the 3-
question headache screen with the International Headache Society (IHS) criteria in the diagnosis of 
migraine among Nigerians. 
METHODS: Using a multi-stage sampling technique, 1513 respondents were screened for migraine 
using both the IHS criteria and the 3-question headache screen. A statistical comparison of the two 
diagnostic methods was then done by determination of kappa coefficient, sensitivity and specificity.  
RESULTS: The prevalence of migraine obtained using the IHS criteria was 9.6% (95% CI, 8.1%-11.1%) 
while it was 8.3% (95% CI, 8.1%-8.5%)with the use of the 3-question headache screen. There was a good 
agreement between the IHS criteria and the 3-question headache screen (k=0.68, p<0.001). The 3-
question headache screen had a sensitivity of 66.2% (95% CI, 58.5%-73.9%), specificity of 97.8% (95% 
CI, 97.0%-98.6%), positive predictive value of 76.2% (95% CI, 68.8%-83.6%) and a negative predictive 
value of 96.5% (95% CI, 95.5%-97.5%). 
CONCLUSION: The 3-question headache screen is sensitive and specific in making a rapid diagnosis of 
migraine among Nigerians. Its use is thus encouraged so that appropriate management of the condition 
can be initiated early in order to reduce  associated disability.  




Although it is rated alongside dementia, psychosis 
and quadriplegia as one of the most disabling 
disorders by the World Health Organization (1), 
migraine is still largely under-diagnosed and 
undertreated (2). This may be particularly worse in 
developing countries where doctor to patient ratio 
is low. In Nigeria, the crude prevalence of 
migraine is 5.3% (3), and we recently reported an 
overall migraine prevalence of 9.6% among 
undergraduates of a Nigerian university (4), but 
this prevalence may just represent the tip of the 
iceberg. 
A simple screening tool will result in a rapid 
recognition of migraine so that appropriate 
management can be commenced without delay. It 
is in recognition of the foregoing that various 
rapid screening methods have been developed for 
the condition (5-7). Cady et al (5) proposed a 3-
question headache screening tool for rapid 
diagnosis of migraine in 2003 and found a good 
correlation between this tool and the International 
Headache Society (IHS) criteria. Similarly, the 
Brief Headache Screen used by Maizels and 
Burchette was found to have a good correlation 
with the diagnoses of headache specialists (8). We 
are not aware of any study that has explored the 
recognition of migraine in Nigeria using any of the 
validated rapid assessment methods. The objective 
of this study was therefore to compare the 
International Headache Society (IHS) criteria with 
the3-question headache screen in thediagnosisof 
migraine in Nigerians. 
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Using a cross-sectional multi-stage sampling 
technique,  students of Ambrose Alli University in 
Southern Nigeria were screened for migraine 
using the International Headache Society (IHS) 
criteria for migraine without aura (9).The study 
protocol was approved by the Ethics Committee of 
Irrua Specialist Teaching Hospital. Data 
acquisition was done by the researchers and 
trained research assistants who were Year 4 
medical students of Ambrose Alli University, 
Ekpoma, Nigeria. The only eligibility criterion for 
inclusion in the study was being a student of 
Ambrose Alli University irrespective of academic 
level. As reported in an earlier publication (4), in 
order to obtain a 95% confidence interval of ±5% 
around an estimated prevalence of migraine of 
16% (10), the calculated minimum sample size 
was 200. The primary sampling unit was however 
increased to 2000 from a sampling frame of 6000 
undergraduate students in order to reduce the 
possibility of type 2 error. Cluster sampling 
technique was used in the selection of 
respondents; each of the 9 Faculties and one 
College of Medicine  in the University at the time 
of the study (January, 2007) was taken as a 
cluster. Each of the clusters had 200 
questionnaires administered on consenting eligible 
respondents based on availability in the lecture 
rooms or hostels on the days of data collection. 
The semi-structured questionnaire used for data 
acquisition was designed to simultaneously obtain 
responses to the International Headache Society 
(IHS) criteria and the 3-questions headache 
screen. The IHS criteria (9) included: 
A. At least 5 attacks fulfilling criteria B–D 
B. Headache attacks lasting 4–72 hours 
(untreated or unsuccessfully treated) 
C. Headache has at least two of the following 
characteristics: 
1. Unilateral location 
2. Pulsating quality 
3. Moderate or severe pain intensity 
4. Aggravation by or causing avoidance of routine 
physical activity (e.g. walking or   climbing stairs) 
D. During headache at least one of the following: 
i. Nausea and/or vomiting 
ii. Photophobia and phonophobia 
E. Not attributed to another disorder 
On the other hand, the  three-question 
headache screen consisted of: 1. Do you have 
recurrent headaches that interfere with work, 
family, or social function?2. Do your headaches 
last at least 4 hours? 3. Have you had new or 
different headaches in the past 6 months?  
Diagnosis of migraine was made if the responses 
to the first 2 questions were yes and the response 
to the last one was no (5).
 
A statistical comparison of the two methods 
of diagnosis was then made with the Statistical 
Package for the Social Sciences version 17 
(SPSS® Inc, Chicago, IL). In order to ascertain 
the measures of agreement between the 3-question 
headache screen and the IHS criteria, kappa 
coefficient was determined. Sensitivity, 
specificity, positive and negative predictive values 
with the appropriate 95% confidence intervals 
were determined as the instrument’s measures of 
validity. A p value <0.05 was taken as a measure 




There were 1513 respondents (males, n= 755) with 
a mean age of 23.3±2.5 years. Using the IHS 
criteria, 145(9.6%; 95% CI, 8.1%-11.1%) of the 
1513 respondents satisfied the criteria for the 
diagnosis of migraine whereas with the use of the 
3-question headache screen, 126(8.3%; 95% CI, 
8.1%-8.5%) were diagnosed. Of the 126 
diagnosed to have migraine based on the 3-
question headache screen, 96 were found to satisfy 
the IHS criteria thus giving a sensitivity of 
66.2%(95% CI, 58.5%-73.9%). There was a good 
agreement between the 3-question headache 
screen and the IHS criteria (k =0.68, p<0.001).  
The specificity was 97.8%(95% CI, 97.0%-
98.6%), positive predictive value was 76.2%(95% 
CI, 68.8%-83.6%) while the negative predictive 
value was 96.5%(95% CI, 95.5%-97.5%). These 












Table 1: Comparison of the 3-question headache screen with the International Headache Society criteria in 
the diagnosis of migraine. 
 
 
Migraine based on 3-question 
headache screen 
Migraine based on IHS criteria 
Present                  Absent 
Total 
Present 96 (a) 30 (b) 126 
Absent 49 (c) 1338 (d) 1387 
Total 145 1368 1513 
Sensitivity =  a/a+c = 96/145 = 66.2% (95% CI=58.5%-73.9%) 
Specificity= d/b+d = 1338/1368 = 97.8% (95% CI= 97.0%-98.6%) 
Positive predictive value = a/a+b = 96/126 = 76.2% (95% CI= 68.8%-83.6%) 




In view of the significant disability associated 
with migraine, its early diagnosis and initiation of 
treatment is imperative. The well-recognized 
diagnostic method for the condition isthe use of 
the International Headache Society criteria (9) 
which can be time-consuming. In addition, except 
for specialists in tertiary hospitals in Nigeria, 
many healthcare practitioners at primary or even 
secondary care levels may not be conversant with 
the diagnostic criteria and this may increase the 
possibility of misdiagnosis of the condition. This 
study has demonstrated a good agreement between 
the International Headache Society criteria and the 
3-question headache screen. The screening tool 
was also found to have a good sensitivity and an 
excellent specificity. 
Compared to the study of Cady et al (5) 
which demonstrated that the 3-question headache 
screen was able to diagnose migraine in 78% of 
the patients enrolled based on the International 
Headache Society criteria, we found that the 
sensitivity of the tool in our respondents was 
66.2%. According to Landis and Koch (11), these 
two values fall within the range of substantial 
concordance in the measurement of observer 
agreement for categorical data. The sensitivity is 
also similar to the high correlation between the 
Brief Headache Screen and headache specialists’ 
diagnoses as reported by Maizels and Burchette 
(6). The ability to screen for those who do not 
have the disease is very good (97.8%) which 
implies that if 100 people are screened using this 
rapid screening method, only 2 are likely to be 
misdiagnosed. The recorded high measures of 
agreement with the International Headache 
Society criteria are also quite comparable to the 
findings of Lainez et al (12) in a validation study 
of Migraine Screen Questionnaire (MS-Q) in 
primary care setting in Spain. A further pointer to 
the good sensitivity of the 3-question headache 
screen in our respondents is the fact that the 
prevalence rate of 8.3% obtained using this 
method falls within the 95% confidence interval 
(8.1%-11.1%) of the prevalence obtained using the 
IHS criteria. This implies that the two values are 
comparable. 
The sensitivity and specificity of the 3-
question Headache Screen in our subjects means 
that it can be used in rapid screening for migraine. 
This is especially important in busy outpatient 
clinics in primary and secondary care hospitals 
where doctor to patient ratio is very low. 
However, in spite of its high specificity and 
negative predictive value, we suggest that this 
instrument should only be used for initial 
assessment in any patient with recurrent 
headaches. Those who have a positive screening 
could then be appropriately referred for further 
evaluation by neurologists or physicians who can 
then apply the IHS criteria to establish the 
diagnosis.  
The main strength of this study is the fact that 
it is the first to validate a rapid assessment method 
for migraine among Nigerians in spite of the 
potentially huge burden of the disease given the 
country’s population. We however appreciate that 
a generalization of the results would be difficult 
because of the small number of migraineurs 
studied which could have increased the possibility 
of type 2 error. However, in a country where there 
have been very few studies on migraine, we 
believe that our findings could serve as a template 
for further studies on this subject. A validation 





study of the screening tool in Nigeria’s major 
indigenous languages will also be necessary since 
a high percentage of the population is illiterate.   
In view of its good agreement with the IHS 
criteria, good sensitivity and specificity, the 3-
question headache screen is a useful tool in the 
rapid recognition of migraine in Nigerians; hence, 
its use should be popularized. Further studies 
using the same tool validated in major Nigerian 
languages are however desirable so that migraine 
can be detected early and use of effective 
preventive and abortive therapies can be 
commenced in order to reduce the burden of the 
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